$2.73T
Total marketcap
$221.85B
Total volume
BTC 50.37%     ETH 16.46%
Dominance

Pharmiva AB (publ) 958.F Stock

0.05 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
1.17M EUR
LOW - HIGH [24H]
0.0000 - 0.0000 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR

Pharmiva AB (publ) Price Chart

Pharmiva AB (publ) 958.F Financial and Trading Overview

Pharmiva AB (publ) stock price 0.05 EUR
Previous Close 0.09 EUR
Open 0.05 EUR
Bid 0.08 EUR x N/A
Ask 0.1 EUR x N/A
Day's Range 0.05 - 0.05 EUR
52 Week Range 0.05 - 0.31 EUR
Volume 5.01K EUR
Avg. Volume 0 EUR
Market Cap 1.13M EUR
Beta (5Y Monthly) 1.835694
PE Ratio (TTM) N/A
EPS (TTM) 0 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

958.F Valuation Measures

Enterprise Value 1.45M EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Pharmiva AB (publ) Stock Price History

Beta (5Y Monthly) 1.835694
52-Week Change -69.48%
S&P500 52-Week Change 20.43%
52 Week High 0.31 EUR
52 Week Low 0.05 EUR
50-Day Moving Average 0.1 EUR
200-Day Moving Average 0.12 EUR

958.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 17.38M
Float 17.31M
Short Ratio N/A
% Held by Insiders 45.63%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 65.46%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -53.43%
Return on Equity (ttm) -98.84%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 153.59%
Gross Profit (ttm) 2.59M EUR
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.18
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 3.877
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Pharmiva AB (publ)

Country Germany
State N/A
City Lund
Address Sankt Lars VAeg 45B
ZIP 22270
Phone 46 4 62 86 51 00
Website https://www.pharmiva.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 5

Pharmiva AB (publ) engages in the research and development of medical products. The company develops Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. Pharmiva AB (publ) is based in Lund, Sweden.

Q&A For Pharmiva AB (publ) Stock

What is a current 958.F stock price?

Pharmiva AB (publ) 958.F stock price today per share is 0.05 EUR.

How to purchase Pharmiva AB (publ) stock?

You can buy 958.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pharmiva AB (publ)?

The stock symbol or ticker of Pharmiva AB (publ) is 958.F.

Which industry does the Pharmiva AB (publ) company belong to?

The Pharmiva AB (publ) industry is Biotechnology.

How many shares does Pharmiva AB (publ) have in circulation?

The max supply of Pharmiva AB (publ) shares is 24.25M.

What is Pharmiva AB (publ) Price to Earnings Ratio (PE Ratio)?

Pharmiva AB (publ) PE Ratio is 0.00000000 now.

What was Pharmiva AB (publ) earnings per share over the trailing 12 months (TTM)?

Pharmiva AB (publ) EPS is 0 EUR over the trailing 12 months.

Which sector does the Pharmiva AB (publ) company belong to?

The Pharmiva AB (publ) sector is Healthcare.